{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:11:16Z","timestamp":1791231076007,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T00:00:00Z","timestamp":1749254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T00:00:00Z","timestamp":1749254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To characterise the clinical and biochemical parameters of children (0\u201316 years) who presented with Diabetic Ketoacidosis (DKA) at a regional hospital in Australia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective observational study was conducted following the approval of the Ethics Committee. Data from 2018 to 2022 were collected from medical records, with a focus on patient treatment and follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 72 type 1 diabetes (T1D) patients with 30 DKA presentations were identified. The mean age at DKA presentation was 11.9 +\/- 3.2 years, with 42.1% having new-onset T1D. An equal number of patients presented with mild (50%) and moderate to severe DKA. Of these, 24 presentations were managed with insulin infusion, and 6 (20%) were managed with subcutaneous insulin. Following a mean ED stay of 7.93 +\/- 4.8\u00a0h, 14 patients (93.3%) were transferred to the CCU or ward, and 2 were transferred to a tertiary centre. The mean HbA1c was 12.55 +\/- 2.1%, with a mean recovery time of 10.4\u00a0h for pH and 6.4\u00a0h for bicarbonate. Minor complications occurred in 10% of patients (all on insulin infusion). All patients were discharged in stable condition after 2.15 +\/- 1.3 days. The follow-up rate was 72.2% (13\/18), with a mean HbA1c of 8.32 +\/- 1.8%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Regional hospitals witness a high frequency of children with T1D presenting with DKA as their first presentation. Targeting bicarbonate levels for acidosis correction could help facilitate an earlier transition to subcutaneous insulin and needs due consideration. This study substantiates the use of upfront subcutaneous insulin for mild to moderate DKA with good outcomes. Follow-up care remains a crucial gap that necessitates strengthening regional diabetes management teams.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12887-025-05824-0","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T22:29:54Z","timestamp":1749248994000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Characterisation of diabetic ketoacidosis in children and adolescents with type 1 diabetes: a regional hospital study"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0888-3069","authenticated-orcid":false,"given":"Sophy","family":"Korula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2568-0247","authenticated-orcid":false,"given":"Sheikh Arif Maqbool","family":"Kozgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd","family":"Bwanaisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,7]]},"reference":[{"key":"5824_CR1","doi-asserted-by":"crossref","unstructured":"Libman I, Haynes A, Lyons S, Pradeep P, Rwagasor E, Tung JY et al. ISPAD clinical practice consensus guidelines 2022: definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes [Internet]. 2022 Dec [cited 2023 Jan 30];23(8):1160\u201374.","DOI":"10.1111\/pedi.13454"},{"issue":"2","key":"5824_CR2","doi-asserted-by":"publisher","first-page":"98","DOI":"10.34172\/hpp.2020.18","volume":"10","author":"M Mobasseri","year":"2020","unstructured":"Mobasseri M, Shirmohammadi M, Amiri T, Vahed N, Hosseini Fard H, Ghojazadeh M. Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis. Health Promotion Perspect [Internet]. 2020;10(2):98\u2013115.","journal-title":"Health Promotion Perspect [Internet]"},{"issue":"10","key":"5824_CR3","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S2213-8587(22)00218-2","volume":"10","author":"GA Gregory","year":"2022","unstructured":"Gregory GA, Robinson TIG, Linklater SE, Wang F, Colagiuri S, de Beaufort C, et al. Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study. Lancet Diabetes Endocrinol. 2022;10(10):741\u201360.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"5824_CR4","unstructured":"Australian Institute of Health and Welfare. 2016. Diabetic ketoacidosis (DKA) among children and young people with type 1 diabetes."},{"key":"5824_CR5","unstructured":"Australian Institute of Health and Welfare. 2020. Prevalence of type 1 Diabetes."},{"issue":"Suppl 12","key":"5824_CR6","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1399-5448.2009.00569.x","volume":"10","author":"J Wolfsdorf","year":"2009","unstructured":"Wolfsdorf J, Craig ME, Daneman D, Dunger D, Edge J, Lee W, et al. Diabetic ketoacidosis in children and adolescents with diabetes. Pediatr Diabetes. 2009;10(Suppl 12):118\u201333.","journal-title":"Pediatr Diabetes"},{"issue":"6","key":"5824_CR7","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.2337\/dc13-1904","volume":"37","author":"FJ Cameron","year":"2014","unstructured":"Cameron FJ, Scratch SE, Nadebaum C, Northam EA, Koves I, Jennings J, et al. Neurological consequences of diabetic ketoacidosis at initial presentation of type 1 diabetes in a prospective cohort study of children. Diabetes Care. 2014;37(6):1554\u201362.","journal-title":"Diabetes Care"},{"issue":"10","key":"5824_CR8","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1177\/0009922815617975","volume":"55","author":"A Patel","year":"2016","unstructured":"Patel A, Singh D, Bhatt P, Thakkar B, Akingbola OA, Srivastav SK. Incidence, trends, and outcomes of cerebral oedema among children with diabetic ketoacidosis in the united States. Clin Pediatr (Phila). 2016;55(10):943\u201351.","journal-title":"Clin Pediatr (Phila)"},{"issue":"6","key":"5824_CR9","doi-asserted-by":"publisher","first-page":"932","DOI":"10.4239\/wjd.v5.i6.932","volume":"5","author":"V Poovazhagi","year":"2014","unstructured":"Poovazhagi V. Risk factors for mortality in children with diabetic ketoacidosis from developing countries. World J Diabetes. 2014;5(6):932\u20138.","journal-title":"World J Diabetes"},{"issue":"4","key":"5824_CR10","doi-asserted-by":"publisher","first-page":"216","DOI":"10.5694\/mja12.10686","volume":"197","author":"FM Claessen","year":"2012","unstructured":"Claessen FM, Donaghue K, Craig M. Consistently high incidence of diabetic ketoacidosis in children with newly diagnosed type 1 diabetes. Med J Aust. 2012;197(4):216.","journal-title":"Med J Aust"},{"issue":"4","key":"5824_CR11","doi-asserted-by":"publisher","first-page":"241","DOI":"10.5694\/mja12.11808","volume":"199","author":"CM Willis","year":"2013","unstructured":"Willis CM, Batch JA, Harris M. Consistently high incidence of diabetic ketoacidosis in children with newly diagnosed type 1 diabetes. Med J Aust. 2013;199(4):241\u20132.","journal-title":"Med J Aust"},{"issue":"5","key":"5824_CR12","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/pedi.12666","volume":"19","author":"R Patwardhan","year":"2018","unstructured":"Patwardhan R, Gorton S, Vangaveti VN, Yates J. Diabetic ketoacidosis incidence in children at first presentation of type 1 diabetes at an Australian regional hospital: the effect of health professional education. Pediatr Diabetes. 2018;19(5):993\u20139.","journal-title":"Pediatr Diabetes"},{"issue":"11","key":"5824_CR13","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/jpc.16673","volume":"60","author":"S Cousen","year":"2024","unstructured":"Cousen S, Hiskens M, Signal D, Vangaveti V, Hariharan G. Incidence and presenting features of paediatric type 1 diabetes mellitus and diabetic ketoacidosis in a regional Australian health service. J Paediatr Child Health. 2024;60(11):730\u20136.","journal-title":"J Paediatr Child Health"},{"key":"5824_CR14","doi-asserted-by":"crossref","unstructured":"Lawrence C, Seckold R, Smart C, King BR, Howley P, Feltrin R et al. Increased paediatric presentations of severe diabetic ketoacidosis in an Australian tertiary centre during the COVID-19 pandemic. Diabet Med. 2020;38(1).","DOI":"10.1111\/dme.14417"},{"key":"5824_CR15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/1742-6723.14320","volume":"36","author":"K-T Kao","year":"2024","unstructured":"Kao K-T, Lei S, Cheek JA, White M, Hiscock H. Paediatric diabetes-related presentations to emergency departments in victoria, Australia from 2008 to 2018. Emerg Med Australasia. 2024;36:101\u20139.","journal-title":"Emerg Med Australasia"},{"issue":"12","key":"5824_CR16","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.2337\/dc22-0853","volume":"45","author":"HF Clapin","year":"2022","unstructured":"Clapin HF, Earnest A, Colman PG, Davis EA, Jefferies C, Anderson K, et al. Diabetic ketoacidosis at onset of type 1 diabetes and Long-term Hba1c in 7,961 children and young adults in the Australasian diabetes data network. Diabetes Care. 2022;45(12):2918\u201325.","journal-title":"Diabetes Care"},{"issue":"8","key":"5824_CR17","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1007\/s00125-020-05152-1","volume":"63","author":"V Cherubini","year":"2020","unstructured":"Cherubini V, Grimsmann JM, \u00c5kesson K, Birkeb\u00e6k NH, Cinek O, Dov\u010d K, et al. Temporal trends in diabetic ketoacidosis at diagnosis of paediatric type 1 diabetes between 2006 and 2016: results from 13 countries in three continents. Diabetologia. 2020;63(8):1530\u201341.","journal-title":"Diabetologia"},{"key":"5824_CR18","unstructured":"Census of Population and Housing. Socio-Economic Indexes for Areas (SEIFA), Australia, 2016."},{"issue":"8","key":"5824_CR19","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.2337\/diacare.28.8.1856","volume":"28","author":"T Della Manna","year":"2005","unstructured":"Della Manna T, Steinmetz L, Campos PR, Farhat SCL, Schvartsman C, Kuperman H, et al. Subcutaneous use of a Fast-Acting insulin analogue: an alternative treatment for pediatric patients with diabetic ketoacidosis. Diabetes Care. 2005;28(8):1856\u201361.","journal-title":"Diabetes Care"},{"issue":"7","key":"5824_CR20","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1111\/pedi.13406","volume":"23","author":"N Glaser","year":"2022","unstructured":"Glaser N, Fritsch M, Priyambada L, Rewers A, Cherubini V, Estrada S, et al. ISPAD clinical practice consensus guidelines 2022: diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes. 2022;23(7):835\u201356.","journal-title":"Pediatr Diabetes"},{"issue":"8","key":"5824_CR21","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.2337\/dc17-1379","volume":"41","author":"D Desai","year":"2018","unstructured":"Desai D, Mehta D, Mathias P, Menon G, Schubart UK. Health care utilisation and burden of diabetic ketoacidosis in the U.S. Over the past decade: A nationwide analysis. Diabetes Care [Internet]. 2018;41(8):1631\u20138. May 17 [cited 2019 Jun 20];.","journal-title":"Diabetes Care [Internet]"},{"issue":"9","key":"5824_CR22","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.2337\/dc17-0558","volume":"40","author":"LM Duca","year":"2017","unstructured":"Duca LM, Wang B, Rewers M, Rewers A. Diabetic ketoacidosis at diagnosis of type 1 diabetes predicts poor Long-term glycemic control. Diabetes Care. 2017;40(9):1249\u201355.","journal-title":"Diabetes Care"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-05824-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-025-05824-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-05824-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T11:03:25Z","timestamp":1751367805000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-025-05824-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,7]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5824"],"URL":"https:\/\/doi.org\/10.1186\/s12887-025-05824-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5928922\/v1","asserted-by":"object"}]},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,7]]},"assertion":[{"value":"30 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors reported that the datasheet of supplementary file may result in a breach of confidentiality as the date of birth is included. Hence, they requested to update the supplementary file accordingly.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study adhered to the Declaration of Helsinki. The approval of Latrobe Regional Health Human Research Ethics Committee (project no. 2023-47 QA), Traralgon, Victoria, Australia, was obtained. A waiver of consent was obtained owing to the study being an audit of practice.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"463"}}